1. Home
  2. UFI vs ATYR Comparison

UFI vs ATYR Comparison

Compare UFI & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unifi Inc. New

UFI

Unifi Inc. New

HOLD

Current Price

$3.28

Market Cap

84.6M

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.73

Market Cap

79.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UFI
ATYR
Founded
1969
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Textiles
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.6M
79.2M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
UFI
ATYR
Price
$3.28
$0.73
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$8.75
AVG Volume (30 Days)
86.2K
2.2M
Earning Date
02-04-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$559,646,000.00
$190,000.00
Revenue This Year
$4.14
N/A
Revenue Next Year
$9.39
$18,728.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.96
$0.64
52 Week High
$6.49
$7.29

Technical Indicators

Market Signals
Indicator
UFI
ATYR
Relative Strength Index (RSI) 41.76 40.44
Support Level $3.19 $0.69
Resistance Level $3.51 $0.83
Average True Range (ATR) 0.22 0.05
MACD 0.01 0.01
Stochastic Oscillator 32.09 19.94

Price Performance

Historical Comparison
UFI
ATYR

About UFI Unifi Inc. New

Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: